Do you send exciting and timely information to your special emailing
group? How about joining the Rumor Mill News Yahoo Group and start sending
RMN your emails?
Find UFOs, The Apocalypse, New World Order, Political Analysis,
Alternative Health, Armageddon, Conspiracies, Prophecies,
Spirituality, Home Schooling, Home Mortgages and more, in:
Perhaps this clarifies the picture we have been given about the arrival any day of the Avian Flu! Only they neglected to add the word vaccine. As you can read below --- that IS arriving. We all know that Big Pharma would not invest so much money without being assured of enormous returns.
So, how do you think this will play? How many will they let die or will the push be on to vaccinate with all the unknown short and long term problems.
REMEMBER, PHARMACEUTICAL COMPANIES ARE NO LONGER LIABLE FOR DAMAGE DONE BY VACCINES. (someone please find the info that this is wrong ---PLEASE!)
ACT NOW TO PROTECT YOUR HEALTH FREEDOM RIGHTS! THE LIFE YOU SAVE MAY BE YOUR OWN.
Chiron Updates Delivery Expectations For U.S. Government H5N1 Vaccine Stockpile Contract
2/24/2006
Emeryville, CA - Chiron Corporation recently announced that the U.S. Department of Health and Human Services (HHS) agreed to extend delivery terms for a stockpile of H5N1 bulk influenza vaccine(1) for the U.S. government. In October 2005, Chiron announced that it had entered into a contract with the U.S. government to stockpile H5N1 bulk vaccine.
Chiron is producing this stockpile at its facility in Liverpool, England, and expects to complete approximately 70 percent of the order before turning operations to annual production of FLUVIRIN(R) influenza virus vaccine in March. Chiron expects to recognize the revenue for the completed doses upon fulfillment of the contract. Chiron expects to resume work on fulfilling the contract following the conclusion of the FLUVIRIN vaccine campaign in the fall of 2006.
As part of its avian influenza vaccine strategy, Chiron expects that it can manufacture avian influenza vaccines during the traditional break between seasonal influenza vaccine campaigns, finishing these activities in time for the seasonal influenza vaccine production to avoid interruption of the normal manufacturing cycle.
